108 related articles for article (PubMed ID: 11939724)
21. Quality control in cytologic screening.
Cecchini S; Grazzini G; Bonardi R; Ciatto S
Acta Cytol; 1993; 37(3):436. PubMed ID: 8498145
[No Abstract] [Full Text] [Related]
22. ["Papanicolaou." Outmoded, isn't it?].
de León-Antoni E
Bol Asoc Med P R; 1991 Oct; 83(10):462-4. PubMed ID: 1789893
[TBL] [Abstract][Full Text] [Related]
23. New Pap test terminology, management guidelines published.
Twombly R
J Natl Cancer Inst; 2002 Jun; 94(12):878-80. PubMed ID: 12072539
[No Abstract] [Full Text] [Related]
24. Response to "access to cervical cancer screening: training internists so skill limitations are not a barrier to care".
Savard M
J Womens Health (Larchmt); 2007 Apr; 16(3):429. PubMed ID: 17439388
[No Abstract] [Full Text] [Related]
25. Rapid review.
Faraker CA
Cytopathology; 1998 Apr; 9(2):71-6. PubMed ID: 9660635
[No Abstract] [Full Text] [Related]
26. Trial quickly changed management of cervical abnormalities.
Zielinski SL
J Natl Cancer Inst; 2005 Apr; 97(7):479-80. PubMed ID: 15812071
[No Abstract] [Full Text] [Related]
27. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
van Kemenade FJ
Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1752. PubMed ID: 18727611
[No Abstract] [Full Text] [Related]
28. [Reproducibility of cytologic diagnosis: study of CRISAP Ile-de-France].
Barrès D; Bergeron C
Gynecol Obstet Fertil; 2000 Feb; 28(2):120-6. PubMed ID: 10758586
[TBL] [Abstract][Full Text] [Related]
29. The challenge of quality improvement with the Papanicolaou smear.
Kline TS
Arch Pathol Lab Med; 1997 Mar; 121(3):253-5. PubMed ID: 9111111
[TBL] [Abstract][Full Text] [Related]
30. Quality control in cytopathology applied to screening for cervical carcinoma.
Marsan C
Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
[TBL] [Abstract][Full Text] [Related]
31. Screening for cervical cancer: recommendations and rationale.
U.S. Preventive Services Task Force
Am J Nurs; 2003 Nov; 103(11):101-2, 105-6, 108-9. PubMed ID: 14625432
[No Abstract] [Full Text] [Related]
32. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Kwee WS; van der Putten HW; Mieremet RH; de Kniff P
Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1751-2; author reply 1752. PubMed ID: 18727610
[No Abstract] [Full Text] [Related]
33. Quality assessment in the age of machine-aided cervical cytology screening.
Renshaw AA
Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
[No Abstract] [Full Text] [Related]
34. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
Greer BE
Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
[TBL] [Abstract][Full Text] [Related]
35. Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.
Bonfiglio TA
Acta Cytol; 1989; 33(4):431-3. PubMed ID: 2750429
[TBL] [Abstract][Full Text] [Related]
36. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
37. [Recommendations from the experimental sites for implementing organized cervical cancer screening in France].
Baudier F; Schapman S; Giordanella JP
Sante Publique; 2000 May; 12 Spec No():71-88. PubMed ID: 10989630
[No Abstract] [Full Text] [Related]
38. NCI makes changes in the Bethesda System.
Am Fam Physician; 1992 Sep; 46(3):967-8. PubMed ID: 1514480
[No Abstract] [Full Text] [Related]
39. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
40. Quality assurance in cervical cytopathology.
Light AM
Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]